(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
-2.53% $ 1.930
Live Chart Being Loaded With Signals
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina...
Stats | |
---|---|
Volumen de hoy | 63 329.00 |
Volumen promedio | 202 739 |
Capitalización de mercado | 75.27M |
EPS | $0 ( 2024-05-04 ) |
Próxima fecha de ganancias | ( $-0.250 ) 2024-06-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.24 |
ATR14 | $0.0130 (0.67%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Doyle John Brendan | Sell | 8 699 | Common Stock |
2024-03-14 | Ricciardi Lisa | Buy | 5 700 | Common Stock |
2024-02-15 | Doyle John Brendan | Buy | 20 000 | Common Stock |
2024-02-15 | Doyle John Brendan | Buy | 20 000 | Stock Option (Right to Buy) |
2024-02-15 | Caggiano Anthony | Buy | 60 000 | Common Stock |
INSIDER POWER |
---|
96.32 |
Last 94 transactions |
Buy: 12 485 685 | Sell: 1 489 688 |
Volumen Correlación
Cognition Therapeutics, Correlación
10 Correlaciones Más Positivas | |
---|---|
BOWXU | 0.909 |
AYLA | 0.897 |
AGCUU | 0.896 |
ASPS | 0.896 |
IRBT | 0.894 |
ARQQ | 0.878 |
AMD | 0.876 |
CELU | 0.875 |
OP | 0.873 |
SNPS | 0.872 |
10 Correlaciones Más Negativas | |
---|---|
IVAC | -0.894 |
ULTA | -0.889 |
ISEM | -0.884 |
PAHC | -0.882 |
CTLP | -0.879 |
RCM | -0.877 |
WFRD | -0.876 |
STAY | -0.872 |
IQ | -0.872 |
IDLB | -0.865 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cognition Therapeutics, Correlación - Moneda/Commodity
Cognition Therapeutics, Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-252 000 (0.00 %) |
EPS: | $-0.860 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-252 000 (0.00 %) |
EPS: | $-0.860 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-235 000 (0.00 %) |
EPS: | $0.0261 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.548 |
Financial Reports:
No articles found.
Cognition Therapeutics,
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinical trial to treat early-stage Alzheimer's disease; in Phase II clinical trial for the treatment of dementia with Lewy bodies (DLB); and in preclinical trial to treat dry age-related macular degeneration (AMD). The company is also developing CT2168 for the treatment of synucleinopathies, which include DLB and Parkinson's disease; and CT2074 to treat dry AMD. Cognition Therapeutics, Inc. was incorporated in 2007 and is headquartered in Purchase, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico